Evidence map›Paper›PMID 33434416›Full record

ArticleImmunity, inflammation and disease2021

RNA m

Xiang Zheng, Jia Wang, Xiaoyue Zhang, Yuxin Fu, Qiu Peng, Jianhong Lu, Lingyu Wei, Zhengshuo Li, Can Liu, Yangge Wu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Immunity, inflammation and disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. The role of NJournal of virology · 2025
    Review
  6. Review
  7. Methyltransferase-like 3-mediated RNA NFrontiers in immunology · 2025
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. mImmunity, inflammation and disease · 2024
    Article
  13. Review
  14. Review
  15. NCellular & molecular biology letters · 2023
    Review
  16. Review
  17. Article
  18. Review
  19. Pseudorabies virus exploits NFrontiers in microbiology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 3 countries.

Xiang ZhengHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Jia WangHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Xiaoyue ZhangCancer Research Institute, Department of Microbiology, Department of Pathology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
Yuxin FuCancer Research Institute, Department of Microbiology, Department of Pathology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
Qiu PengCancer Research Institute, Department of Microbiology, Department of Pathology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
Jianhong LuCancer Research Institute, Department of Microbiology, Department of Pathology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
Lingyu WeiCancer Research Institute, Department of Microbiology, Department of Pathology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
Zhengshuo LiCancer Research Institute, Department of Microbiology, Department of Pathology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
Can LiuCancer Research Institute, Department of Microbiology, Department of Pathology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
Yangge WuDepartment of Pathology, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Qun YanDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jian MaHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.ORCID 0000-0001-9395-0416
Central South University · CNGuilin Medical University · CN

Funding

111 Project 111-2-12China 111 Project 111-2-12National Natural Science Foundation of China 32000665National Natural Science Foundation of China 81874170National Natural Science Foundation of China 82060042National Natural Science Foundation of China 82073261Natural Science Foundation of Hunan Province, China 2020JJ5480
6 · The paper itself

Abstract

introductionN

methodsMethylated RNA immunoprecipitation sequencing (MeRIP-seq) and MeRIP-RT-qPCR were used to determine the m

resultsHere, we provided mechanistic insights by examining the viral and cellular m

conclusionsThese results reveal the critical role of m

Indexed as

Epstein-Barr Virus InfectionsDNA MethylationEpstein-Barr Virus Nuclear AntigensHerpesvirus 4, HumanHumansRNAEpstein-Barr Virus Nuclear AntigensRNABHRF1EBNA2Epstein-Barr virusMETTL3RNA m6A methylation

Identifiers

PMID33434416
PMCPMC8127537
OpenAlexW3120230978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.